Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Statin Consumer Medication Guides Requested By HRG In Wake Of Baycol

Executive Summary

FDA should issue mandatory medication guides warning consumers about the risk of rhabdomyolysis and death with use of statin cholesterol-lowering drugs, the Public Citizen's Health Research Group said in an Aug. 20 petition.
Advertisement

Related Content

AERS Database Cannot Determine Adverse Event Incidence, FDA Says In Rejecting Statin Label Warning
AstraZeneca Defends Crestor; Public Citizen Renews Call For Withdrawal
AstraZeneca Defends Crestor; Public Citizen Renews Call For Withdrawal
AstraZeneca Crestor Should Be Withdrawn For Safety Risks – Public Citizen
AstraZeneca Crestor Should Be Withdrawn For Safety Risks – Public Citizen
Bristol Pravachol 80 Mg Long-Term Safety Data Is Phase IV Commitment
Bristol Pravachol 80 Mg Long-Term Safety Data Is Phase IV Commitment
Baycol Withdrawal Gives Boost To Pravachol; Will Crestor NDA Be Affected?
Baycol Withdrawal Gives Boost To Pravachol; Will Crestor NDA Be Affected?
Cholesterol Therapy Guidelines Stress Need To Consider Cost, Treat To Goal
Advertisement
UsernamePublicRestriction

Register

PS038421

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel